Werewolf Therapeutics Stock Price on December 14, 2024
| HOWL Stock | USD 1.65 0.06 3.51% |
If you're considering investing in Werewolf Stock, it is important to understand the factors that can impact its price. As of today, the current price of Werewolf Therapeutics stands at 1.65, as last reported on the 14th of December 2024, with the highest price reaching 1.71 and the lowest price hitting 1.62 during the day. Werewolf Therapeutics shows Sharpe Ratio of -0.0205, which attests that the company had a -0.0205% return per unit of risk over the last 3 months. Werewolf Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Werewolf Therapeutics' Mean Deviation of 4.66, standard deviation of 7.6, and Market Risk Adjusted Performance of (0.06) to validate the risk estimate we provide.
Stock Based Compensation To Revenue is expected to rise to 0.47 this year, although the value of Total Stockholder Equity will most likely fall to about 68.3 M. . At this time, Werewolf Therapeutics' Price Book Value Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 0.09 this year, although the value of Price Earnings Ratio will most likely fall to (3.87). Werewolf Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Werewolf |
Sharpe Ratio = -0.0205
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HOWL |
Estimated Market Risk
| 7.58 actual daily | 67 67% of assets are less volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Werewolf Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Werewolf Therapeutics by adding Werewolf Therapeutics to a well-diversified portfolio.
Price Book 0.8526 | Enterprise Value Ebitda 0.5683 | Price Sales 24.3479 | Shares Float 25.6 M | Wall Street Target Price 12 |
Werewolf Therapeutics Main Headline on 13th of December 2024
Werewolf Therapeutics, Inc. Shares Sold by Point72 Asset Man... by thelincolnianonline.com
Point72 Asset Management L.P. trimmed its holdings in Werewolf Therapeutics, Inc. by 70.5 percent during the third quarter, HoldingsChannel.com reports. The firm owned 109,816 shares of the companys stock after selling 261,861 shares during the period. Point72 Asset Management L.P.s holdings in Werewolf Therapeutics were worth 233,000 as of its most recent
Werewolf Therapeutics Valuation on December 14, 2024
It is possible to determine the worth of Werewolf Therapeutics on a given historical date. On December 14, 2024 Werewolf was worth 1.68 at the beginning of the trading date compared to the closed value of 1.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Werewolf Therapeutics stock. Still, in general, we apply an absolute valuation method to find Werewolf Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Werewolf Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Werewolf Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.82 | 1.85 | 1.68 | 1.71 | 429,925 | |
12/13/2024 | 1.68 | 1.71 | 1.62 | 1.65 | 363,275 |
| Backtest Werewolf Therapeutics | | | Werewolf Therapeutics History | | | Werewolf Therapeutics Valuation | Previous |
Werewolf Therapeutics Trading Date Momentum on December 14, 2024
| On December 13 2024 Werewolf Therapeutics was traded for 1.65 at the closing time. The top price for the day was 1.71 and the lowest listed price was 1.62 . The trading volume for the day was 363.3 K. The trading history from December 13, 2024 had no short-term effect on price fluctuation. The trading price change against the current closing price is 1.82% . |
Werewolf Therapeutics Fundamentals Correlations and Trends
By evaluating Werewolf Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Werewolf Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Werewolf financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Werewolf Therapeutics Stock history
Werewolf Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Werewolf is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Werewolf Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Werewolf Therapeutics stock prices may prove useful in developing a viable investing in Werewolf Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 35.6 M | 32.8 M | |
| Net Loss | -61.9 M | -58.8 M |
Werewolf Therapeutics Quarterly Net Working Capital |
|
Werewolf Therapeutics Stock Technical Analysis
Werewolf Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Werewolf Therapeutics Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Werewolf Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Werewolf Therapeutics December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Werewolf Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Werewolf Therapeutics shares will generate the highest return on investment. By undertsting and applying Werewolf Therapeutics stock market strength indicators, traders can identify Werewolf Therapeutics entry and exit signals to maximize returns
Werewolf Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Werewolf Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Werewolf Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Werewolf to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (1.11) | |||
| Treynor Ratio | (0.07) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Werewolf Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. If investors know Werewolf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Werewolf Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 0.082 | Quarterly Revenue Growth (0.86) | Return On Assets (0.26) | Return On Equity (0.62) |
The market value of Werewolf Therapeutics is measured differently than its book value, which is the value of Werewolf that is recorded on the company's balance sheet. Investors also form their own opinion of Werewolf Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Werewolf Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Werewolf Therapeutics' market value can be influenced by many factors that don't directly affect Werewolf Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Werewolf Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.